As EGFR expression in cancer may be linked to the epithelial-mesenchymal transition (EMT), and as EMT may impede the effect of EGFR-directed therapies [12], we analyzed the mRNA and protein expression of EMT factors in DFSP center, DFSP infiltrative periphery and DFSP-T higher-grade sarcoma areas. The gene discussed is EGFR; the disease is cancer.